Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Pablo Tamayo et al.|Nature|2009Cited by 4.2k
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Anthony Letai, Craig H. Mermel et al.|Nature|2010Cited by 4.1k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017Cited by 2k
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M. Johannessen, Levi A. Garraway, Jesse S. Boehm et al.|Nature|2010Cited by 1.4k
Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Rohith T. Nagari et al.|Nature Cancer|2020Cited by 880